Minimally Invasive Surgery
The Mount Sinai Department of Urology physicians have pioneered the adoption of minimally invasive treatments for a wide range of urologic diseases and disorders. We are among the established specialists in the country for robotic surgery, laparoscopic surgery, endoscopic surgery, and laser surgery.
Our physicians evaluate the unique needs of each patient to determine the best surgical approach. When appropriate, minimally invasive approaches are preferred because they allow less tissue damage, faster recovery time, and less scarring than open surgery.
Robotic surgery has moved to the forefront of modern urologic surgery, and Mount Sinai urologists perform robotic surgery for prostate, kidney, ureter, and bladder conditions. As a group, we are one of the busiest robotic surgery programs in the United States, performing well over 700 robotic procedures a year. In particular our experts are at the leading edge of robotic surgery for prostate and kidney cancer. Dr. David B. Samadi oversees the robotic surgery program for prostate cancer while Dr. Michael Palese’s robotic surgery practice is focused on kidney cancer and the reconstruction of kidney abnormalities in adults. Dr. Jeffrey A. Stock is a pediatric surgeon who has performed successful robotic surgery on children as young as eight months old, including major reconstructive procedures.
The Department of Urology's physicians at Mount Sinai are renowned in laparoscopic surgery. Dr. Simon Hall and many of our other faculty are noted experts and thought leaders in this field, who teach national and international courses to other physicians. Using small openings in the abdominal and pelvic cavity, surgical procedures can be performed without the need of making large incisions. These techniques are routinely used in urologic surgery involving the kidney (particularly for kidney cancer removal and donor transplant surgery) and for surgery of the adrenal glands. Partial nephrectomy (where only the tumor is removed and the major portion of the kidney is allowed to remain intact) has also become a standard procedure.
Endoscopic surgery (minimally invasive procedures that employ an endoscope, a tiny video camera) includes: cystoscopy, ureteroscopy, and percutaneous nephrolithotomy/nephrolithotripsy. Our physicians perform thousands of these procedures every year with particular focus on the minimally invasive treatment of benign prostatic hyperplasia (BPH) and kidney stone disease.
Lasers are now a common tool used to treat kidney stones and BPH. Our physicians have access to the newest technologies in this area and are well versed with all types of laser surgery treatments, including GreenLight™ laser and Holmium laser treatments.
We Can Help
Mount Sinai’s Department of Urology is ranked among the nation’s best by US News and World Report. Please call us at 212-241-4812 to learn how our physicians can provide an in-depth evaluation to ensure optimal treatment for you or your loved one based on your medical profile and needs
The Department of Urology
5 East 98th Street, 6th Floor
New York, NY 10029
Dr. Michael Palese, Director of Minimally Invasive Surgery, removes a kidney tumor using the daVinci robot.